Status:

COMPLETED

Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

Lead Sponsor:

University of California, San Diego

Collaborating Sponsors:

Children's Hospital Colorado

University of Colorado, Denver

Conditions:

Kawasaki Disease

Eligibility:

All Genders

2-17 years

Phase:

PHASE1

PHASE2

Brief Summary

Kawasaki disease (KD) is the leading cause of acquired heart disease in children in the developed world. Despite available treatment, 25% of children in San Diego County appropriately treated for KD d...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age ≥ 2 years to 17 years old
  • Meets clinical criteria for KD according to American Heart Association guidelines (Table 2): Fever (T≥38oC or 100.4oC) ≥ 3 days and ≥ 2 clinical criteria with left anterior descending coronary artery/right coronary artery z-score ≥ 2.5 or an aneurysm (≥ 1.5 x the adjacent segment) of one of the coronary arteries
  • Patient presents within the first 20 days after fever onset
  • Parent or legal guardian able and willing to provide informed consent and subject willing and able to provide assent when appropriate.
  • Post-menarchal females: Negative pregnancy test at screening and willing to use two forms of contraception during the study
  • Males engaging in sexual activity that could lead to pregnancy must use a condom.
  • Exclusion Criteria:
  • Use of a statin, fibrate, or niacin within the 3 months prior to enrollment
  • Have any chronic disease, except asthma, atopic dermatitis, autism or controlled seizure disorder
  • Screening creatine phosphokinase (CK) ≥ 3x upper limit of normal for age
  • Patient taking a CYP3A4 inhibitor (ie. cyclosporine or clarithromycin) in the last 7 days
  • Patient has a history of allergy to atorvastatin or its derivatives

Exclusion

    Key Trial Info

    Start Date :

    July 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2018

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT01431105

    Start Date

    July 1 2012

    End Date

    July 1 2018

    Last Update

    May 6 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of California San Diego

    San Diego, California, United States, 92093

    Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities | DecenTrialz